Viral Genome Sequencing: Technologies, Bioinformatics, and Public Health Applications

Viral genome sequencing determines the complete nucleotide sequence of a virus's RNA or DNA genome. It is foundational to molecular epidemiology, outbreak response, vaccine design, and antiviral development.

Sequencing Technologies

  • Sanger (capillary electrophoresis): Gold standard for accuracy (99.99%); low throughput; used for confirmation, short regions, resistance mutations.
  • Short-read NGS (Illumina): Massive parallel sequencing (millions of 150–300 bp reads); high accuracy, low cost/base; dominant for viral surveillance. Requires PCR/amplicon or metagenomic library prep.
  • Long-read (Oxford Nanopore, PacBio HiFi): Nanopore: real-time, portable (MinION), native RNA sequencing, detects modifications; reads >100 kb. PacBio HiFi: >99.9% accuracy, 10–25 kb reads. Enable full-genome haplotypes, structural variants, direct RNA.
  • Targeted amplicon vs. metagenomic: Amplicon (PrimalSeq, ARTIC)—high depth, low cost, primer-dependent. Metagenomic—unbiased, detects co-infections, novel viruses; higher cost, host depletion needed.

Bioinformatics Pipeline

  1. Quality control (FastQC, fastp).
  2. Host subtraction (human genome alignment).
  3. Assembly: reference-guided (minimap2, bwa) or de novo (SPAdes, metaSPAdes).
  4. Consensus generation (iVar, bcftools); coverage/quality thresholds.
  5. Lineage assignment (Pangolin, Nextclade for SARS-CoV-2; custom for others).
  6. Phylogenetics (IQ-TREE, Nextstrain/auspice)—transmission clusters, emergence.
  7. Variant annotation (SnpEff, VEP); surveillance for VOC/VOI defining mutations.
  8. Recombination detection (RDP4, GARD).
  9. Selection analysis (dN/dS, FUBAR, MEME).

Public Health Applications

  1. Outbreak investigation: Transmission chains, superspreading, nosocomial clusters.
  2. Variant surveillance: Early detection of VOCs (Alpha, Delta, Omicron sublineages); phenotypic inference (immune escape, transmissibility).
  3. Vaccine matching: Antigenic drift monitoring; strain selection (WHO GISRS for influenza).
  4. Antiviral resistance: Neuraminidase (H275Y), polymerase (PA-I38T), protease (Mpro) mutations.
  5. Zoonotic spillover: Animal reservoir sequencing; risk assessment (e.g., sarbecoviruses, henipaviruses).
  6. Molecular clock dating: TMRCA estimation; origin timing.
  7. Wastewater surveillance: Community-level trend tracking (SARS-CoV-2, polio, influenza).

Challenges and Standards

  • Data sharing: GISAID, GenBank, INSDC; metadata standards (MIxS, GSC).
  • Quality thresholds: >90% genome coverage, >100× mean depth, <0.5% ambiguity.
  • Bioinformatics reproducibility: containerized pipelines (Nextflow, Snakemake), version control.
  • Ethical/legal: Nagoya Protocol, benefit-sharing, patient privacy.
  • Global equity: Sequencing capacity gaps (Africa, parts of Asia/LatAm); capacity-building initiatives (Africa CDC, WHO BioHub).

Viral sequencing has transitioned from research tool to public health infrastructure. Sustained investment in global genomic surveillance is essential for pandemic preparedness.

Viral Infections - Related Articles